Regulatory mechanisms of the gut microbiota-short chain fatty acids signaling axis in slow transit constipation and progress in multi-target interventions
Top Cited Papers
Open Access
- 24 November 2025
- journal article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16
Abstract
Slow-transit constipation (STC) is an increasingly prevalent disorder that imposes a substantial health and economic burden. Mounting evidence highlights the “gut microbiota–short-chain fatty acid (SCFA)–motility” axis as a central pathophysiological link between dysbiosis and impaired colonic transit. This review synthesizes current knowledge of how SCFAs, especially acetate, propionate and butyrate, shape motility through serotonergic signaling, enteric nervous system modulation, epithelial barrier integrity and immune regulation. Particular attention is devoted to the biased-signaling properties of the SCFA receptors FFAR2 and FFAR3 (free fatty acid receptors 2 and 3, respectively), including emerging data on their heterodimerization. The article then appraises recent randomized controlled trials and meta-analyses of multi-target interventions (dietary fibers, synbiotics, postbiotics, fecal microbiota transplantation, phytochemicals, and small-molecule FFAR agonists) highlighting their efficacy, safety, and translational hurdles. Finally, the authors propose a precision-medicine framework that integrates multi-omics microbiome profiling, metabolomics, and host genetics to enable phenotype-stratified therapy. Key research gaps include limited long-term safety data, heterogeneous human cohorts and the need for large multicenter trials and machine-learning-guided responder prediction. Collectively, the review provides a roadmap for shifting STC management from symptom control to mechanism-based, personalized care.Keywords
This publication has 94 references indexed in Scilit:
- Differential Gut Microbiota, Dietary Intakes in Constipation Patients with or without HypertensionMolecular Nutrition & Food Research, 2023
- Interstitial cells of Cajal: clinical relevance in pediatric gastrointestinal motility disordersPediatric Surgery International, 2023
- Shouhui Tongbian Capsules induce regression of inflammation to improve intestinal barrier in mice with constipation by targeted binding to Prkaa1: With no obvious toxicityBiomedicine & Pharmacotherapy, 2023
- miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kitIndian Journal of Gastroenterology, 2021
- Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular DiseaseCurrent Atherosclerosis Reports, 2020
- Evaluation of 124I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized miceActa Pharmaceutica Sinica B, 2020
- Acetate Promotes T Cell Effector Function during Glucose RestrictionCell Reports, 2019
- The Central Nervous System and the Gut MicrobiomeCell, 2016
- Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseasesJournal of Gastroenterology, 2016
- Oral domperidone has no additional effect on chronic functional constipation in children: A randomized clinical trialIndian Journal of Gastroenterology, 2013